Abstract:Objective:To evaluate the effect of calcium channel blocker (CCB) amlodipine combined with larger dose of angiotensin Ⅱ type 1 receptor blocker (ARB) valsartan on improving left ventricular diastolic dysfunction (LVDD) in postmenopausal hypertensive women patients with left ventricular hypertrophy (LVH).Methods:This prospective, open parallel controlled study enrolled 103 natural postmenopausal women patients aged 45-65 years with hypertension and LVH who presented in Lanzhou University Second Hospital from December 2016 to April 2017. Patients were divided into group A and group B. The former group was given amlodipine (5 mg/d) plus higher dose of valsartan (160~320 mg/d), and the latter group was given amlodipine (5 mg/d) plus valsartan (80 mg/d). All patients were followed up for 18 months. The serum biochemical indexes, renin angiotensin system (RAS) components, type Ⅰ and type Ⅲ collagen, 8-hydroxy- deoxyguanosine (8-OHdG), superoxide dismutase (SOD), glutathione (GSH) and α-smooth muscle actin (α-SMA) were detected before and after treatment of 18 months. Moreover, mean 24-hour ambulatory blood pressure, load value and coefficient of variation, and ambulatory arterial stiffness index (AASI) were evaluated. Cardiac structure, systolic and diastolic function were assessed by echocardiography.Results:(1) There were no significant differences in clinical characteristics between the two groups when enrolled (all P>0.05). (2) Patients on both group have reached the target blood pressure on 24-hour ambulatory blood pressure monitoring without significant difference. However, the AASI level of group A after treatment was lower than that before treatment and group B after treatment (all P<0.05). (3) There were no significant differences in oxidative stress and myocardial fibrosis parameters between the two groups before and after treatment (all P>0.05). (4) After 18 months of treatment, angiotensin (1-7), angiotensin (1-9) and angiotensin converting enzyme 2 (ACE2) were increased while ACE levels were decreased significantly (all P<0.05) in the group A, whereas only angiotensin (1-7) increased in the group B ( P<0.05). (5) The interventricular septum thickness at end-diastole and left ventricular mass decreased, the ratio of early diastolic peak flow velocity (E) to early diastolic mitral annular velocity (e′) (E/e′) decreased and the ratio of e′ to late diastolic mitral annular velocity (a′) (e′/a′) increased significantly (all P<0.05), indicating the improvement of LVDD in the group A, while no similar changes were observed in the group B. (6) The occurrence of adverse events was similar between the two groups (all P>0.05). Conclusion:CCB combined with a larger dose of ARB can improve the LVDD of postmenopausal women patients with hypertension and LVH to a certain extent.

A1613 the Relationship Between the Levels of Sexual Hormones and Left Ventricular Hypertrophy in Postmenopausal Hypertensive Women

STUDY ON THE RELATIONSHIP BETWEEN LEFT VENTRICULAR GEOMETRY AND SERUM PROCOLLAGEN TYPE Ⅰ AND TYPE Ⅲ IN ESSENTIAL HYPERTENSIVE PATIENTS

Left Ventricular Geometry and the Levels of Plasma B-type Natriuretic Peptide and Serum Procollagen TypeⅢ in Essential Hypertensive Patients

Relationship Between Androgen Levels and Pathological Changes of Coronary Atherosclerosis in Elderly Males

The Nfluence of Conjugested Estrogen Therapy on Cardiovascular Function in Postmenopausal Women

A0748 The specific effect of testosterone on nocturnal systolic blood pressure and left ventricular diastolic dysfunction in postmenopausal hypertensive women

The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women.

Cia_a_195498 743..752

Relationship Between Hypertensive Left Ventricular Hypertrophy and Levels of Endothelin and Nitric Oxide.

Impact of gender on left ventricular deformation in patients with essential hypertension assessed by cardiac magnetic resonance tissue tracking

The value of relationship among endothelial function、endothelin and estrogen in peri-menopausal women by ultrasonography

Value of Electrocardiographic Left Ventricular Hypertrophy As a Predictor of Poor Blood Pressure Control

Analysis of the Associations Between Obesity Indices and Left Ventricular Mass

Association of Female Menopause With Atrioventricular Mechanics and Outcomes

Correlation research of left ventricualr hypertrophy and metabolic index in elderly male patients with hypertension

Improving Asymptomatic Left Ventricular Diastolic Dysfunction in Postmenopausal Hypertensive Women with Metabolic Syndrome: A Prospective, Open-Labeled, Randomized Controlled Trial.

Luteinizing hormone is independently associated with high-sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross-sectional study

GW28-e1212 Value of Electrocardiographic Left Ventricular Hypertrophy As a Predictor of Poor Blood Pressure Control: Evidence from the China Stroke Primary Prevention Trial

Clinical Study on the Effect of Calcium Channel Blocker Combined with Angiotensin Ⅱ Type 1 Receptor Blocker on Left Ventricular Diastolic Dysfunction in Postmenopausal Hypertension Women Patients with Left Ventricular Hypertrophy

Disordered Gut Microbiome and Alterations in Metabolic Patterns Are Associated With Hypertensive Left Ventricular Hypertrophy

Study on Factors Associated with Left Ventricular Hypertrophy in the Old